Related Experiment Videos
The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome
1Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke's Hospital, United Kingdom.
Abstract:
Different specific mutations in the ret tyrosine kinase give rise to different clinical types of the inherited cancer syndrome multiple endocrine neoplasia type 2 (MEN 2). The explanation for these genotype-phenotype correlations is not yet certain. Several lines of evidence suggest that they result either from different levels of RET activation induced by different mutations or, in one class of mutation, possibly from altered substrate specificity of the RET tyrosine kinase. ret is expressed during development in a lineage of neuroectodermal cells that gives rise to the thyroid C cells and the adrenal medulla, which are involved in tumor formation in MEN 2. ret is also expressed in the enteric autonomic nervous system. Inactivating mutations of ret lead to Hirschsprung's disease, a congenital absence or maldevelopment of the enteric plexuses, whereas activating mutations in one variety of the MEN 2 syndrome lead to their overgrowth. The range of phenotypic expression seen in families with different ret mutations and the variation within families with the same mutation provide a potentially interesting and tractable system for the analysis of both the relationship between phenotype and genotype and the effects of modifier genes.
Insights
Specific mutations in the ret tyrosine kinase cause different types of multiple endocrine neoplasia type 2 (MEN 2). These genetic changes may alter RET activation or substrate specificity, influencing disease presentation.
Area of Science:
- Genetics
- Oncology
- Developmental Biology
Background:
- Multiple endocrine neoplasia type 2 (MEN 2) is an inherited cancer syndrome.
- Specific mutations in the ret tyrosine kinase gene are linked to distinct MEN 2 clinical subtypes.
- The precise mechanisms underlying these genotype-phenotype correlations remain unclear.
Purpose of the Study:
- To investigate the genotype-phenotype correlations in MEN 2.
- To explore the potential roles of RET activation levels and substrate specificity in MEN 2 pathogenesis.
- To analyze the influence of modifier genes on phenotypic variability in MEN 2.
Main Methods:
- Analysis of ret tyrosine kinase mutations.
- Correlation of specific mutations with clinical manifestations of MEN 2.
- Examination of ret gene expression patterns in relevant tissues.
Main Results:
- Different ret mutations are associated with distinct MEN 2 clinical presentations.
- Evidence suggests altered RET activation or substrate specificity contributes to MEN 2 phenotypes.
- ret expression in neuroectodermal derivatives (thyroid C cells, adrenal medulla, enteric nervous system) is implicated in MEN 2 development.
Conclusions:
- Genotype-phenotype correlations in MEN 2 are driven by specific ret mutations.
- The ret pathway's role in neurocristopathies like MEN 2 and Hirschsprung's disease is highlighted.
- MEN 2 families offer a model for studying genotype-phenotype relationships and genetic modifiers.